DEUTSCHE BANK AG\ - MEDICAL TRANSCRIPTION BLG CO ownership

MEDICAL TRANSCRIPTION BLG CO's ticker is MTBC and the CUSIP is 58464J105. A total of 11 filers reported holding MEDICAL TRANSCRIPTION BLG CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MEDICAL TRANSCRIPTION BLG CO
ValueSharesWeighting
Q4 2018$19,000
+850.0%
5,150
+635.7%
0.00%
Q1 2018$2,000
-66.7%
700
-72.0%
0.00%
Q4 2017$6,000
+100.0%
2,500
+4.2%
0.00%
Q3 2017$3,0002,400
+380.0%
0.00%
Q2 2017$0500
+254.6%
0.00%
Q1 2015$0
-100.0%
141
-93.9%
0.00%
Q3 2014$8,0002,3060.00%
Other shareholders
MEDICAL TRANSCRIPTION BLG CO shareholders Q2 2018
NameSharesValueWeighting ↓
SILVERBACK ASSET MANAGEMENT LLC 247,486$881,0000.10%
AlphaOne Investment Services, LLC 56,672$202,0000.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,005,000$3,578,0000.01%
Tower Research Capital LLC (TRC) 1,584$6,0000.00%
GOLDMAN SACHS GROUP INC 39,182$139,0000.00%
MORGAN STANLEY 19$00.00%
BlackRock Investment Management, LLC 491$2,0000.00%
DEUTSCHE BANK AG\ 2,306$8,0000.00%
View complete list of MEDICAL TRANSCRIPTION BLG CO shareholders